RJA
TRIB

Raymond James & Associates’s Trinity Biotech TRIB Stock Holding History

Raymond James & Associates’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,906
Closed -$74K – 3589
2017
Q4 		$74K Sell
2,906
-3,606
-55% -$93K ﹤0.01% 3247
2017
Q3 		$183K Buy
6,512
+1,501
+30% +$41.9K ﹤0.01% 3076
2017
Q2 		$150K Sell
5,011
-359
-7% -$10.2K ﹤0.01% 3057
2017
Q1 		$160K Sell
5,370
-211
-4% -$6.6K ﹤0.01% 2987
2016
Q4 		$193K Sell
5,581
-353
-6% -$12.2K ﹤0.01% 2892
2016
Q3 		$392K Sell
5,934
-31
-0.5% -$1.93K ﹤0.01% 2440
2016
Q2 		$338K Buy
5,965
+298
+5% +$16.8K ﹤0.01% 2339
2016
Q1 		$330K Buy
5,667
+136
+2% +$7.22K ﹤0.01% 2269
2015
Q4 		$325K Buy
5,531
+160
+3% +$9.44K ﹤0.01% 2166
2015
Q3 		$307K Buy
5,371
+1
+0% +$80 ﹤0.01% 2123
2015
Q2 		$485K Sell
5,370
-44
-0.8% -$3.81K ﹤0.01% 2106
2015
Q1 		$521K Sell
5,414
-43
-0.8% -$3.97K ﹤0.01% 2023
2014
Q4 		$478K Sell
5,457
-353
-6% -$30.4K ﹤0.01% 1962
2014
Q3 		$531K Sell
5,810
-1,246
-18% -$135K ﹤0.01% 1829
2014
Q2 		$812K Buy
7,056
+1,688
+31% +$200K 0.01% 1614
2014
Q1 		$650K Sell
5,368
-3,053
-36% -$400K ﹤0.01% 1660
2013
Q4 		$1.06M Buy
8,421
+302
+4% +$36.2K 0.01% 1297
2013
Q3 		$883K Buy
8,119
+2,618
+48% +$255K 0.01% 1323
2013
Q2 		$463K Buy
+5,501
New +$456K ﹤0.01% 1547

Other funds holding TRIB

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

Raymond James & Associates's TRIB Position: Q1 2018 in Review

Raymond James & Associates sold out of Trinity Biotech (TRIB) in Q1 2018, closing a stake of 2,906 shares — an estimated $74K sold.

Raymond James & Associates first reported a position in TRIB in Q2 2013 and held it in 19 quarters. The position peaked at $1.06M in Q4 2013. 45 funds tracked by Wall St. Rank hold TRIB as of Q1 2018.

  • Raymond James & Associates reported no remaining Trinity Biotech position as of Q1 2018 after selling out during the quarter.
  • Raymond James & Associates sold 2,906 Trinity Biotech shares in Q1 2018, an estimated $74K.
  • Raymond James & Associates first reported a position in Trinity Biotech in Q2 2013 and held it in 19 quarters.
  • Raymond James & Associates's Trinity Biotech position peaked at $1.06M in Q4 2013.
  • 45 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2018.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.